Pyc Therapeutics
Biotechnology, Boston Ma Us, San Francisco, California, United States, 51-200 Employees
Who is PYC THERAPEUTICS
PYC Therapeutics (ASX: PYC) is a clinical stage biotechnology company pioneering a new generation of RNA therapeutics for genetic diseases. It works by combining two complementary platfor...
Read More
-
Headquarters: Boston Ma Us, San Francisco, California, United States
-
Date Founded: 2005
-
Employees: 51-200
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 7389
Does something look wrong? Fix it. | View contact records from PYC THERAPEUTICS
PYC Therapeutics Org Chart and Mapping
Email
Phone
Subrata Das
Senior Director, Chemistry, Manufacturing, and Controls. Head of Drug Product Development
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding PYC Therapeutics
Answer: PYC Therapeutics's headquarters are located at Boston Ma Us, San Francisco, California, United States
Answer: PYC Therapeutics's official website is https://pyctx.com
Answer: PYC Therapeutics's revenue is Under $1 Million
Answer: PYC Therapeutics's SIC: 7389
Answer: PYC Therapeutics has 51-200 employees
Answer: PYC Therapeutics is in Biotechnology
Answer: PYC Therapeutics contact info: Phone number: Website: https://pyctx.com
Answer: PYC Therapeutics (ASX: PYC) is a clinical stage biotechnology company pioneering a new generation of RNA therapeutics for genetic diseases. It works by combining two complementary platforms: RNA-based drug design and PYCs proprietary drug delivery technology. PYC's library of naturally derived cell penetrating peptides provide its delivery platform to overcome the major challenges of RNA therapeutics - getting into the target cell. PYC believes its PPMO (Peptide conjugated Phosphorodiamidate Morpholino Oligomer) technology enables a safer and more effective RNA therapeutic to address the underlying drivers of a range of genetic diseases for which no treatment solutions exist today. The Company is leveraging its leading-edge science to develop a pipeline of novel therapies including two programs focused on inherited eye diseases and preclinical discovery efforts focused on neurodegenerative diseases. PYCs discovery and laboratory operations are located in Australia, and the Companys preclinical and clinical operations are based in San Fransisco California.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month